[SCHEDULE 13D/A] GAMCO Natural Resources, Gold & Income Trust SEC Filing
Saba Capital Management and related persons report holding 1,353,496 common shares of GAMCO Natural Resources, Gold & Income Trust (GNT), representing 8.36% of the outstanding shares based on 16,198,039 shares as of 6/30/25. The filing is Amendment No. 3 to a Schedule 13D and updates Items 3, 5 and 7. Funds used to acquire the shares came from investor subscriptions, capital appreciation and margin borrowings, and approximately $6,876,341 was paid for the shares reported. The filing states the shares were acquired in the open market and that Saba-advised funds have rights to dividends and sale proceeds.
- Transparent disclosure of beneficial ownership totaling 1,353,496 shares (8.36%)
- Source of funds clearly described with total consideration of approximately $6,876,341
- Open-market acquisition disclosure indicates no private placement or negotiated purchase
- None.
Insights
TL;DR: Saba discloses an 8.36% beneficial stake acquired with ~$6.88M; transaction appears to be open-market accumulation, not an activist demand.
The Schedule 13D/A reports a non-trivial 8.36% ownership by Saba Capital, Saba GP and Boaz Weinstein, aggregated at 1,353,496 shares. The filing clarifies source of funds and that purchases were effected in the open market and are held in advisory accounts that receive dividends and sale proceeds. This is material disclosure under Section 13D because it notifies the market of concentrated ownership, but the filing contains no statements of intent to seek control or propose transactions. Impact is informational: it may attract investor attention but does not by itself change corporate governance or operational plans.
TL;DR: The amended Schedule 13D provides required beneficial ownership detail and provenance of funds, without announcing activist plans.
The amendment updates Items 3, 5 and 7 and confirms shared voting and dispositive power for the reporting persons. Signatures and a cited power of attorney are included, supporting regulatory completeness. The filing does not disclose litigation, regulatory issues, or any proposed nominations or transactions. From a governance perspective, this is a standard disclosure of concentrated shareholding that merits monitoring but does not itself signal a change in board composition or strategy.